
Oragenics OGEN
€ 0.51
1.72%
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Oragenics DPO 2011-2026 | OGEN
DPO Jährlich Oragenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | 291 | 478 | 265 | 183 | 323 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 478 | 183 | 308 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Amgen
AMGN
|
64.8 | $ 345.82 | 1.71 % | $ 186 B | ||
|
Amneal Pharmaceuticals
AMRX
|
21.1 | $ 12.61 | 2.35 % | $ 3.95 B | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 24.35 | 4.64 % | $ 3.1 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.44 | 5.51 % | $ 383 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.74 | 6.42 % | $ 17.2 M | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Cerus Corporation
CERS
|
242 | $ 1.94 | 5.43 % | $ 370 M | ||
|
CTI BioPharma Corp.
CTIC
|
306 | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.79 K | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.2 K | - | - | $ 2.18 B | ||
|
Dynavax Technologies Corporation
DVAX
|
52.8 | - | - | $ 2.02 B | ||
|
Coherus BioSciences
CHRS
|
507 | $ 1.68 | 0.6 % | $ 197 M |